Some improvements were also observed in terms of their cardiovascular health (Pi-Sunyer, Astrup, Fukuoka)
Obesity raises the odds of developing cardiovascular disease, type 2 diabetes, stroke, certain malignancies, sleep apnea, and lung diseases
Zangabad PS, Vasani RB, Tong Z, Anderson D, Rudd D, Hick CA, et al
GLP-1 acts as a key signalling molecule in this network, informing the brain about our nutritional status
The landscape of GLP-1 therapy continues to evolve rapidly
In addition, researchers found that participants cardiometabolic improvements reverted once their weight returned to their baseline and they regained what they had just lost